Flow cytometric tests have found rather low NRP1 levels in benign prostate epithelial cell lines and demonstrated elevated NRP1 levels in tumor cells with increased metastatic potential, with the highest expression found in mCRPC cells. This evidence concerns the gene NRP1 and neoplasm.